Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Oracle Corp.

Start price
Target price
Perf. (%)
€40.34
02.04.18
€180.00
22.10.24
248.59%
12:15

buy
Intel Corp.

Start price
Target price
Perf. (%)
€32.36
13.06.17
€72.16
22.10.24
12.65%
12:21

buy
Intel Corp.

Start price
Target price
Perf. (%)
€32.36
13.06.17
€72.16
22.10.24
12.65%
12:21

buy
Intel Corp.

Start price
Target price
Perf. (%)
€32.36
13.06.17
€72.16
22.10.24
12.65%
12:21

buy
Intel Corp.

Start price
Target price
Perf. (%)
€32.36
13.06.17
€72.16
22.10.24
12.65%
12:21

buy
Oracle Corp.

Start price
Target price
Perf. (%)
€34.93
01.12.16
€145.00
08.09.26
304.92%
12:15

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
High dividend yield expected
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.28%
12:16

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.28%
12:16

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.28%
12:16

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€18.07
30.09.16
€125.00
08.09.26
439.88%
12:12

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Good rating
Low dividend yield expected
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€18.07
30.09.16
€125.00
08.09.26
439.88%
12:12

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Good rating
Low dividend yield expected